Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil

NCT01475123 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

268

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
End Stage Renal Disease

Interventions

DRUG: Nicorandil

Sponsor

Kumamoto University